Tech Company Financing Transactions

Meditope Biosciences Funding Round

On 7/27/2013, Meditope Biosciences secured $3.6 million in Series A funding from private investors.

Transaction Overview

Announced On
7/27/2013
Transaction Type
Venture Equity
Amount
$3,600,000
Round
Series A
Investors
Proceeds Purpose
The company will use the proceeds to accelerate development of its antibody-based cancer products.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
177 E. Colorado Blvd. 200
Pasadena, CA 91105
USA
Email Address
Overview
Discovered at City of Hope, Meditope's technology is capable of turning any monoclonal antibody (mAb) into a proprietary, site-specific Lego-like system that is able to attach and detach drugs to antibodies without the need for chemical conjugation.
Profile
Meditope Biosciences LinkedIn Company Profile
Social Media
Meditope Biosciences Company Twitter Account
Company News
Meditope Biosciences News
Facebook
Meditope Biosciences on Facebook
YouTube
Meditope Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
Michael Goldberg
  Michael Goldberg LinkedIn Profile  Michael Goldberg Twitter Account  Michael Goldberg News  Michael Goldberg on Facebook
Chief Executive Officer
Stephanie Hsieh
  Stephanie Hsieh LinkedIn Profile  Stephanie Hsieh Twitter Account  Stephanie Hsieh News  Stephanie Hsieh on Facebook
Chief Financial Officer
Michael Hsieh
  Michael Hsieh LinkedIn Profile  Michael Hsieh Twitter Account  Michael Hsieh News  Michael Hsieh on Facebook
Chief Scientific Officer
David Stover
  David Stover LinkedIn Profile  David Stover Twitter Account  David Stover News  David Stover on Facebook
VP - Bus. Development
Robert McKenzie
  Robert McKenzie LinkedIn Profile  Robert McKenzie Twitter Account  Robert McKenzie News  Robert McKenzie on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/26/2013: aPriori Technologies venture capital transaction
Next: 7/27/2013: Realm venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary